KEVIN VIDAL: Open Payments
NPI 1407476401 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 35 payments from 21 companies in 2025. Trend: 2023 $538 · 2024 $437 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $229 |
| DePuy Synthes Sales Inc. | 1 | $141 |
| Orthofix Medical, Inc. | 1 | $138 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| Alexion Pharmaceuticals, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| ABBVIE INC. | 2 | $48 |
| Neurelis, Inc. | 2 | $46 |
| TG Therapeutics, Inc. | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $30 |
Products named: NA, Spinal-Stim, Fintepla, Nayzilam, ACTHAR, ULTOMIRIS, WAINUA, BOTOX.
Industry payments across FL — which companies pay providers there.
